German industrial production dipped in March – data    Dollar gains ground, yen weakens on Wednesday    India eyes 7% growth, downplays inflation worries – advisor    Egypt, Jordan prepare for 32nd Joint Committee Meeting in Cairo    Banque Misr announces strategic partnership with Belmazad digital auction platform    Egypt's PM oversees progress of Warraq Island development    Egypt, World Bank evaluate 'Managing Air Pollution, Climate Change in Greater Cairo' project    Russian court seizes $13m from JPMorgan, Commerzbank    Amazon to invest $8.88b into Singapore cloud infrastructure    Health Ministry on high alert during Easter celebrations    Egypt warns of Israeli military operation in Rafah    US academic groups decry police force in campus protest crackdowns    US Military Official Discusses Gaza Aid Challenges: Why Airdrops Aren't Enough    US Embassy in Cairo announces Egyptian-American musical fusion tour    ExxonMobil's Nigerian asset sale nears approval    Egypt, France emphasize ceasefire in Gaza, two-state solution    Japanese Ambassador presents Certificate of Appreciation to renowned Opera singer Reda El-Wakil    Sweilam highlights Egypt's water needs, cooperation efforts during Baghdad Conference    AstraZeneca injects $50m in Egypt over four years    Egypt, AstraZeneca sign liver cancer MoU    Swiss freeze on Russian assets dwindles to $6.36b in '23    Amir Karara reflects on 'Beit Al-Rifai' success, aspires for future collaborations    Climate change risks 70% of global workforce – ILO    Prime Minister Madbouly reviews cooperation with South Sudan    Egypt retains top spot in CFA's MENA Research Challenge    Egyptian public, private sectors off on Apr 25 marking Sinai Liberation    Debt swaps could unlock $100b for climate action    President Al-Sisi embarks on new term with pledge for prosperity, democratic evolution    Amal Al Ghad Magazine congratulates President Sisi on new office term    Egyptian, Japanese Judo communities celebrate new coach at Tokyo's Embassy in Cairo    Uppingham Cairo and Rafa Nadal Academy Unite to Elevate Sports Education in Egypt with the Introduction of the "Rafa Nadal Tennis Program"    Financial literacy becomes extremely important – EGX official    Euro area annual inflation up to 2.9% – Eurostat    BYD، Brazil's Sigma Lithium JV likely    UNESCO celebrates World Arabic Language Day    Motaz Azaiza mural in Manchester tribute to Palestinian journalists    Russia says it's in sync with US, China, Pakistan on Taliban    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



UK-based pharmaceutical firm to purchase Egypt's EPCI
Multinational Hikma Pharmaceutical to buy Egyptian Company for Pharmaceuticals & Chemical Industries (EPCI)for $22.2 million, company announces Wednesday
Ahram Online Published in Ahram Online on 09 - 01 - 2013

Hikma Pharmaceutical plans to acquire the Egyptian Company for Pharmaceuticals & Chemical Industries (EPCI), according to a Wednesday press release issued by the UK-based multinational.
The company said it would pay LE142.4 million (approximately $22.2 million) for the Egyptian pharmaceutical firm.
Hikma attributed its decision to buy EPCI to the fact that the Egyptian pharmaceutical market represents one of the largest and fastest growing markets in the Middle East/North Africa region.
"Since we entered the Egyptian market in 2007, we have been rapidly growing our presence," Hikma CEO Said Darwazah said. "This acquisition will further accelerate that growth, expanding our product portfolio and adding additional manufacturing capacity and technologies."
IMS Health, a leading provider of information, services and technology for the healthcare industry, estimates that the private retail market in Egypt – currently valued at around $2.3 billion – grew by 10.6 per cent in the 12 months to June 2012.
Hikma, which is listed on the London Stock Exchange, first entered the Egyptian pharmaceutical market in 2007 through its acquisition of Alkan Pharma in Egypt, now Hikma-Egypt.
Hikma-Egypt is currently the seventeenth largest pharmaceutical manufacturer in the country, with an estimated market share of 1.6 per cent.
http://english.ahram.org.eg/News/62099.aspx

Clic here to read the story from its source.